Not applicableStudy completedNCT01213641
What this trial is testing
Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients
Who this might be right for
Cryopyrin-associated Periodic Syndromes (CAPS)Familial Cold Autoinflam Syn (FCAS)Muckle-wells Syn (MWS)+1 more
Novartis Pharmaceuticals 288